BackAtara Biotherapeutics Overview
Atara Biotherapeutics Inc

Atara Biotherapeutics Target Price

Explore Atara Biotherapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.54

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-08Canaccord Genuity$1352.2% upsideOpen
2026-01-13New Street$629.7% downsideOpen
2025-12-19Canaccord Genuity$25192.7% upsideOpen
2024-11-13Stifel NicolausBenjamin Burnett$1017.1% upsideOpen
2024-08-16Mizuho SecuritiesSalim Syed$18110.8% upsideOpen
2022-08-09Goldman Sachs$364.9% downsideOpen
2022-05-24Goldman Sachs$453.2% downsideOpen

Atara Biotherapeutics (ATRA) FAQ

Stockcircle tracks target price for Atara Biotherapeutics (ATRA), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Atara Biotherapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ATRA overview so you can move from this figure to the surrounding analysis quickly.